- Filed
- Nov 3, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Oct 30, 2025 | 17.05B sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 8.67K sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 8.59K sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 8.34K sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 8.44K sh |
| Capex | Q3 2025 · Sep 30, 2025 | $0 |
| Capex | Q3 2025 · Sep 30, 2024 | $195K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$63.54M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$101.68M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $37.67M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $62.48M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $72.83M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$269.26M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$238.93M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$186.02M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$159.65M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$132.14M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$136.21M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $87.16M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $92.26M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $365.49M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $350.44M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $89.75M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $156.46M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $96.23M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $164.42M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$3.82 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$10.93 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$3.85 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$10.40 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$3.82 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$10.93 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$3.85 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$5.68 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $26.61M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $82.44M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $27.63M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $88.25M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $30.54M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $97.95M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $36.13M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $109.93M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$33.13M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$93.84M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$32.07M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$45.64M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$15.22M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$72.86M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$26.28M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$88.16M |
| Revenue | Q3 2025 · Sep 30, 2025 | $44.04M |
| Revenue | Q3 2025 · Sep 30, 2025 | $111.99M |
| Revenue | Q3 2025 · Sep 30, 2024 | $38.78M |
| Revenue | Q3 2025 · Sep 30, 2024 | $114.7M |